Showing results (161-170 of 918) with videos related to
Sort By:
Pageof 92
Cancer Treatment Reviews|December 4, 2013
Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: focus on trabectedinAndrés Poveda, Isabelle Ray-Coquard, Ignacio Romero, et al.Ultrasonics Sonochemistry|January 27, 2016
A versatile sonication-assisted deposition-reduction method for preparing supported metal catalysts for catalytic applicationsRomen Herrera Padilla, Peter Priecel, Ming Lin, et al.Anticancer Research|October 15, 2010
Active surveillance for low-risk prostate cancerRoberta Mazzucchelli, Ioannis Nesseris, Liang Cheng, et al.Analytical and Quantitative Cytology and Histology|August 13, 2010
Comparison between incidentally and clinically detected prostate cancer: implications for prostate cancer screening programs and focal therapyRoberta Mazzucchelli, Rodolfo Montironi, Doriana Morichetti, et al.Analytical and Quantitative Cytology and Histology|August 27, 2005
Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic featuresRoberta Mazzucchelli, Francesca Barbisan, Daniela Stramazzotti, et al.Journal of Proteomics|June 18, 2013
Proteomic perspective of Quercus suber somatic embryogenesisAranzazu Gomez-Garay, Juan Antonio Lopez, Emilio Camafeita, et al.Histopathology|December 14, 2016
Iatrogenic changes in the urinary tractAntonio Lopez-Beltran, Gladell P Paner, Rodolfo Montironi, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|December 20, 2007
Expression of OCT4 transcription factor in cutaneous neoplasiaTerrence M Katona, Steven D Billings, Rodolfo Montironi, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|May 28, 2010
Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasiaKurt B Hodges, Antonio Lopez-Beltran, Robert E Emerson, et al.Current Drug Targets|December 4, 2014
Morphologic and molecular backgrounds for personalized management of genito-urinary cancers: an overviewRodolfo Montironi, Matteo Santoni, Antonio Lopez-Beltran, et al.Pageof 92